AAAAAA

   
Results: 1-10 |
Results: 10
Relation between HIV-1 and hepatitis C viral load in patients with hemophilia
Authors: Daar, ES Lynn, H Donfield, S Gomperts, E Hilgartner, MW Hoots, WK Chernoff, D Arkin, S Wong, WY Winkler, CA
Citation: Es. Daar et al., Relation between HIV-1 and hepatitis C viral load in patients with hemophilia, J ACQ IMM D, 26(5), 2001, pp. 466-472
Use of sand bathing for the treatment of arthritis and other conditions
Authors: Dilixat, Y Aytulun, S Mayiram, S Arkin, S Ibadet, R Sekine, M Kagamimori, S
Citation: Y. Dilixat et al., Use of sand bathing for the treatment of arthritis and other conditions, ALTERN TH H, 7(6), 2001, pp. 24-24
Discourse analysis of Alzheimer's patients before and after intervention: Methodology and outcomes
Authors: Arkin, S Mahendra, N
Citation: S. Arkin et N. Mahendra, Discourse analysis of Alzheimer's patients before and after intervention: Methodology and outcomes, APHASIOLOGY, 15(6), 2001, pp. 533-569
Hepatitis c virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs
Authors: Daar, ES Lynn, H Donfield, S Gomperts, E O'Brien, SJ Hilgartner, MW Hoots, WK Chernoff, D Arkin, S Wong, WY Winkler, CA
Citation: Es. Daar et al., Hepatitis c virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs, J INFEC DIS, 183(4), 2001, pp. 589-595
Effects of stathmin inhibition on the mitotic spindle
Authors: Iancu, C Mistry, SJ Arkin, S Wallenstein, S Atweh, GF
Citation: C. Iancu et al., Effects of stathmin inhibition on the mitotic spindle, J CELL SCI, 114(5), 2001, pp. 909-916
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
Authors: Silverman, LB Gelber, RD Dalton, VK Asselin, BL Barr, RD Clavell, LA Hurwitz, CA Moghrabi, A Samson, Y Schorin, MA Arkin, S Declerck, L Cohen, HJ Sallan, SE
Citation: Lb. Silverman et al., Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01, BLOOD, 97(5), 2001, pp. 1211-1218
Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven (R) emergency-use programme in patients with severe haemophilia or with acquired inhibitors
Authors: Arkin, S Blei, F Fetten, J Foulke, R Gilchrist, GS Heisel, MA Key, N Kisker, CT Kitchen, C Shafer, FE Shah, PC Strickland, D
Citation: S. Arkin et al., Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven (R) emergency-use programme in patients with severe haemophilia or with acquired inhibitors, BL COAG FIB, 11(3), 2000, pp. 255-259
Taxol and anti-stathmin therapy: A synergistic combination that targets the mitotic spindle
Authors: Iancu, C Mistry, SJ Arkin, S Atweh, GF
Citation: C. Iancu et al., Taxol and anti-stathmin therapy: A synergistic combination that targets the mitotic spindle, CANCER RES, 60(13), 2000, pp. 3537-3541
Changes in hepatitis B serologic titers in HIV+ and HIV- children with haemophilia
Authors: Kisker, CT Mahoney, EM Arkin, S Maeder, MA Donfield, SM Evatt, BL
Citation: Ct. Kisker et al., Changes in hepatitis B serologic titers in HIV+ and HIV- children with haemophilia, HAEMOPHILIA, 5(5), 1999, pp. 354-359
Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors - Results of the NovoSeven emergency-use program
Authors: Arkin, S Cooper, HA Hutter, JJ Miller, S Schmidt, ML Seibel, NL Shapiro, A Warrier, I
Citation: S. Arkin et al., Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors - Results of the NovoSeven emergency-use program, HAEMOSTASIS, 28(2), 1998, pp. 93-98
Risultati: 1-10 |